Approaches to Diagnosis and Risk Assessment for Patients With MDS

Dr Jamie L. Koprivnikar describes her general approaches to diagnosing and risk stratifying patients with myelodysplastic syndrome, and how she differentiates high-risk and low-risk disease.

EP: 1.Case Presentation: A 72-Year-Old Woman with Single Lineage Dysplasia Myelodysplastic Syndrome (MDS)

Now Viewing

EP: 2.Approaches to Diagnosis and Risk Assessment for Patients With MDS

EP: 3.Differences in Treatment Approaches for Low-Risk and High-Risk MDS

EP: 4.Current Unmet Needs for Patients With Low-Risk MDS in the Frontline Setting

EP: 5.Luspatercept as a Treatment Option in MDS

EP: 6.Efficacy and Safety of Luspatercept in MDS: Key Data from the COMMANDS Trial

EP: 7.Rationale Surrounding Luspatercept as Potential First-Line Treatment Option for Patients With MDS

EP: 8.Future Perspectives and Unmet Needs for Patients With MDS

Related Videos